An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 10606058)

Published in Arch Dermatol on December 01, 1999

Authors

P A Klein1, R A Clark

Author Affiliations

1: Department of Dermatology, State University of New York at Stony Brook, 11794-8165, USA. PKLEIN00@yahoo.com

Articles citing this

The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci (2007) 2.63

Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci (2008) 2.40

Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest (2006) 1.90

The excimer lamp induces cutaneous nerve degeneration and reduces scratching in a dry-skin mouse model. J Invest Dermatol (2014) 1.39

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol (2014) 1.32

Sensory neurons and circuits mediating itch. Nat Rev Neurosci (2014) 1.26

An Alternative Approach to Atopic Dermatitis: Part II-Summary of Cases and Discussion. Evid Based Complement Alternat Med (2004) 1.23

Chronic pruritus: clinics and treatment. Ann Dermatol (2011) 0.94

Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. J Invest Dermatol (2012) 0.90

Management of itch in atopic dermatitis. Semin Cutan Med Surg (2011) 0.89

H1 antihistamines: current status and future directions. World Allergy Organ J (2008) 0.87

The histamine H4 receptor: from orphan to the clinic. Front Pharmacol (2015) 0.80

Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin. Biomol Ther (Seoul) (2012) 0.80

Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology (2006) 0.80

Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol (2014) 0.79

No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review. Syst Rev (2014) 0.79

A Comprehensive Review of the Treatment of Atopic Eczema. Allergy Asthma Immunol Res (2016) 0.78

Understanding the pathophysiology of itch. Dermatol Ther (2013) 0.78

Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr (2016) 0.78

Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesions. J Med Food (2014) 0.77

Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin. Int J Mol Sci (2016) 0.76

Synergistic antipruritic effects of gamma aminobutyric acid A and B agonists in a mouse model of atopic dermatitis. J Allergy Clin Immunol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Cutaneous wound healing. N Engl J Med (1999) 19.12

Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89

Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol (1983) 5.73

Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61

Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21

Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15

Angiogenesis in wound healing. J Investig Dermatol Symp Proc (2000) 3.12

Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice. BMJ (1995) 2.77

Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56

Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. J Exp Med (1975) 2.56

Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci U S A (1989) 2.49

The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45

Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med (1977) 2.45

Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest (1991) 2.38

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35

Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol (1982) 2.29

Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells. Blood (1975) 2.25

Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science (1988) 2.21

What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20

Wound repair in the context of extracellular matrix. Curr Opin Cell Biol (1994) 2.14

Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol (1990) 2.12

Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol (1982) 2.10

Does passive smoking increase the frequency of health service contacts in children with asthma? Thorax (2001) 2.04

Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01

Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun (1982) 1.99

In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol (1984) 1.99

Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity. J Immunol (1977) 1.98

Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med (1995) 1.95

Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract (1996) 1.94

Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J Biol Chem (1991) 1.92

The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91

Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest (1980) 1.89

Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88

Cutaneous tissue repair: basic biologic considerations. I. J Am Acad Dermatol (1985) 1.86

Relationships between the rate of synthesis of ATP and the concentrations of reactants and products of ATP hydrolysis in maize root tips, determined by 31P nuclear magnetic resonance. Arch Biochem Biophys (1985) 1.78

Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils. J Immunol (1979) 1.77

Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin. Immunochemistry (1972) 1.73

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol (1985) 1.72

Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem (1995) 1.69

Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci (1997) 1.67

NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem (1987) 1.66

Preoperative evaluation of patients for liver resection. Appropriate CT imaging. Ann Surg (1993) 1.65

Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils. J Biol Chem (1981) 1.65

Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59

Advising parents of asthmatic children on passive smoking: randomised controlled trial. BMJ (1999) 1.57

Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56

Hemolysis and iodination of erythrocyte components by a myeloperoxidase-mediated system. Blood (1975) 1.56

Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol (1987) 1.55

The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity. J Immunol (1981) 1.47

Myeloperoxidase--H2O2--halide system: cytotoxic effect on human blood leukocytes. Blood (1977) 1.45

Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. J Immunol (1981) 1.42

Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med (1973) 1.42

Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils. Science (1994) 1.39

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol (1989) 1.39

Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1979) 1.39

Interactive effects of salinity and phosphorus nutrition of the concentrations of phosphate and phosphate esters in mature photosynthesizing corn leaves. Plant Physiol (1976) 1.39

Screening mammography in the Tampa Bay area: current status and implications for the next decade. J Fla Med Assoc (1989) 1.39

Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis (2001) 1.38

Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol (2000) 1.38

Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol (1996) 1.36

Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun (1977) 1.36

The facilitator effect: results from a four-year follow-up of children with asthma. Br J Gen Pract (1997) 1.36

Deep venous thrombosis: detection by using indirect CT venography. The Pulmonary Angiography-Indirect CT Venography Cooperative Group. Radiology (2000) 1.35

Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol (1982) 1.35

Fibronectin is produced by blood vessels in response to injury. J Exp Med (1982) 1.35

Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis (2000) 1.34

Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med (1985) 1.34

Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol (1996) 1.32

Markov random field for tumor detection in digital mammography. IEEE Trans Med Imaging (1995) 1.32

TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol (1994) 1.31

Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol (1988) 1.31

Complications of central venous catheterization. AJR Am J Roentgenol (1979) 1.27

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer (1985) 1.27

Neutrophil chemotaxis in systemic lupus erythematosus. Ann Rheum Dis (1974) 1.22

Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am Rev Respir Dis (1991) 1.21

Interactions between human granulocytes and Blastomyces dermatitidis. Infect Immun (1979) 1.21

Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine. J Immunol (1980) 1.21

Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Qual Life Res (2003) 1.20

Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res (1997) 1.19

How general practitioners manage acute asthma attacks. Thorax (1997) 1.19

Neutrophils autoinactivate secretory products by myeloperoxidase-catalyzed oxidation. Blood (1985) 1.19

Cytotoxicity for tumor cells of cationic proteins from human neutrophil granules. J Cell Biol (1976) 1.18

Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization. Biochem J (1994) 1.17

The effect of beta-adrenoceptor agonists and antagonists on gastric emptying in man. Br J Clin Pharmacol (1980) 1.17

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy. J Clin Oncol (1988) 1.17

Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects. J Clin Oncol (1985) 1.17

Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation. J Immunol (1982) 1.16

Cefazolin in the treatment of bacterial pneumonia. J Infect Dis (1973) 1.13

Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax (1995) 1.12

Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav (2007) 1.12

A three-dimensional collagen lattice induces protein kinase C-zeta activity: role in alpha2 integrin and collagenase mRNA expression. J Cell Biol (1997) 1.11

A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol (1998) 1.09

Role of macrophages in would healing. Surg Forum (1976) 1.09

Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem (1989) 1.09

Fibronectin, as well as other extracellular matrix proteins, mediate human keratinocyte adherence. J Invest Dermatol (1985) 1.09

The application of fractal analysis to mammographic tissue classification. Cancer Lett (1994) 1.08

PU.1 is essential for p47(phox) promoter activity in myeloid cells. J Biol Chem (1997) 1.08